# Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE)

> **NCT03873714** · NA · TERMINATED · sponsor: **Medtronic Neurovascular Clinical Affairs** · enrollment: 14 (actual)

## Conditions studied

- Intracranial Aneurysm

## Interventions

- **DEVICE:** Pipeline™ Vantage Embolization Device with Shield Technology™

## Key facts

- **NCT ID:** NCT03873714
- **Lead sponsor:** Medtronic Neurovascular Clinical Affairs
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-02
- **Primary completion:** 2021-07-22
- **Final completion:** 2023-09-18
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** The study enrollment was halted on 14-Jun-2020. The study was not resumed and was terminated on 06-Jun-2024. Participants are no longer being examined or receiving intervention. Sponsor is no longer pursuing clinical evidence from the ADVANCE study.
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03873714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03873714, "Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03873714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*